-
Clinical Characteristics, Treatment Patterns, and Drug-Resistant Epilepsy Among Emirati Adults with Epilepsy
-
Real‐world effectiveness of cenobamate in drug‐resistant and ultra‐refractory epilepsy: A multicenter study
-
Anti‐Seizure Medications Alter Functional and Effective Connectivity as Measured With Intracranial Electroencephalography
-
Hypophosphatemia in the first seizure clinic: Data from a second UK center
-
Effectiveness of adjunctive low‐dose clobazam in adults with focal drug‐resistant epilepsy and incomplete response to cenobamate: A real‐world study
-
Peculiar Clinical Manifestation in a Child With Self-Limited Epilepsy With Autonomic Seizures (SeLEAS) Presenting in an All-Four Position: A Case Report
-
Perampanel as add‐on in high‐grade glioma–related epilepsy: Seizure control and QoL in a prospective, multicenter, real‐world 6‐month follow‐up study
-
Efficacy, Safety, and Tolerability of Atogepant in Migraine Patients from the UAE
-
Trajectories of quality of life, anxiety and depressive symptomatology, and health‐related work productivity after first seizure events
-
Beyond seizures: A multidimensional approach to non‐seizure issues in Lennox–Gastaut syndrome. Insights from Italian experts
-
Predictors of treatment efficacy in mesial temporal lobe epilepsy and focal epilepsies of other localisations
-
Incorporation bias in clinical prediction models for epilepsy
-
The Global Epilepsy Needs Study (GENS): A mixed‐methods, multi‐country exploration of the unmet psychosocial and everyday needs of people with epilepsy
-
Pulse‐based photoplethysmography quality assessment improves wearable seizure detection performance
-
Widening participation in the International League Against Epilepsy: Looking to the future
-
The Burden of Epilepsy in Thailand: Estimating Societal Costs and Quality of Life
-
Clinical Characteristics of Over‐The‐Counter Drug Misusers in Psychiatric Practice in Japan: Comparison by Type of Drug Misused for the First Time
-
Relationship between hTERT levels and oxidative stress in epilepsy patients
-
”Not always the magic bullet”—Insufficient seizure control by ketogenic dietary therapies in Glut1 Deficiency Syndrome
-
The future of epilepsy care in the United Kingdom: A roadmap for technology‐enabled transformation
-
Postmortem MRI reveals distinct structural features in sudden unexpected death in epilepsy
-
Occurrence and clinical correlates of depressive symptoms in adults with epilepsy: A study in Georgia
-
Factors Associated With Antiseizure Medication Adherence in Patients With Epilepsy: A Systematic Review
-
Safety and Efficacy of Obinutuzumab β (MIL62), a Novel Glycoengineered Type II Anti-CD20 Monoclonal Antibody, in Patients with Neuromyelitis Optica Spectrum Disorder: A Multicenter, Single-Arm, Phase Ib Clinical Trial
